/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png
0
0
Info
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png
Info2016-10-17 16:55:362021-01-07 12:21:42Effects of a human recombinant alkaline phosphatase on renal hemodynamics, oxygenation and inflammation in two models of acute kidney injury
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png
0
0
Info
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png
Info2016-09-27 16:53:262021-01-07 12:21:46Study protocol for a multicentre randomised controlled trial: Safety, Tolerability, efficacy and quality of life Of a human recombinant alkaline Phosphatase in patients with sepsis-associated Acute Kidney Injury (STOP-AKI)
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png
0
0
Info
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png
Info2016-09-22 17:06:502021-01-07 12:21:53Human recombinant alkaline phosphatase inhibits ex vivo platelet activation in humans
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png
0
0
Info
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png
Info2016-05-04 16:58:542021-01-07 12:21:59Pharmacokinetic Modeling and Dose Selection in a Randomized, Double-Blind, Placebo-Controlled Trial of a Human Recombinant Alkaline Phosphatase in Healthy Volunteers
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png
0
0
Info
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png
Info2015-08-29 16:56:582021-01-07 12:22:05Biodistribution and translational pharmacokinetic modeling of a human recombinant alkaline phosphatase
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png
0
0
Info
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png
Info2015-07-29 16:16:542021-01-07 12:22:10Alkaline phosphatase protects against renal inflammation through dephosphorylation of lipopolysaccharide and adenosine triphosphate